Cranberry proanthocyanidins inhibit esophageal adenocarcinoma <i>in vitro</i> and <i>in vivo</i> through pleiotropic cell death induction and PI3K/AKT/mTOR inactivation
Laura A. Kresty(Medical College of Wisconsin), Amy B. Howell(Cranberry Institute)
Cited by 66
Related Papers
Inhibition of the Adherence of P-Fimbriated<i>Escherichia coli</i>to Uroepithelial-Cell Surfaces by Proanthocyanidin Extracts from Cranberries
|New England Journal of Medicine|1998|435
Cranberry Polyphenols in Esophageal Cancer Inhibition: New Insights
|Nutrients|2022|16
Cranberry Proanthocyanidins Mitigate Reflux-Induced Transporter Dysregulation in an Esophageal Adenocarcinoma Model
|Pharmaceuticals|2023|4
Proteomic Profiling Informs Mechanisms of Esophageal Adenocarcinoma Inhibition by Cranberry Proanthocyanidins
|Molecular Nutrition & Food Research|2025|3